Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3338601000168117 | Bonjela Teething (choline salicylate 87 mg / 1 g) gel (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3338611000168119 | Bonjela Teething 8.7% gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bonjela Teething 8.7% gel | has manufactured dose form | gel | true | Inferred relationship | Some | ||
| Bonjela Teething 8.7% gel | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bonjela Teething 8.7% gel | Is a | Bonjela Teething | true | Inferred relationship | Some | ||
| Bonjela Teething 8.7% gel | Is a | choline salicylate 8.7% gel | true | Inferred relationship | Some | ||
| Bonjela Teething 8.7% gel | has manufactured dose form | oral gel | false | Inferred relationship | Some | ||
| Bonjela Teething 8.7% gel | has Australian BoSS | choline salicylate | true | Inferred relationship | Some | 109237296 | |
| Bonjela Teething 8.7% gel | has intended active ingredient | salicylic acid | true | Inferred relationship | Some | 109237296 | |
| Bonjela Teething 8.7% gel | has unit of use | continuous | true | Inferred relationship | Some | 109237297 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bonjela Teething 8.7% gel, 15 g | has TPUU | True | Bonjela Teething 8.7% gel | Inferred relationship | Some | 1 |
| Bonjela Teething 8.7% gel, 15 g, tube | has TPUU | True | Bonjela Teething 8.7% gel | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR